CHEN, Z.-S.; YANG, D.-H. Selection of optimal therapeutic modality for early-stage extranodal natural killer/T-cell lymphoma patients under the guidance of single-nucleotide polymorphism signature. Bosnian Journal of Basic Medical Sciences, 24 Aug. 2021.